4.7 Review

The role of basic leucine zipper transcription factor E4BP4 in the immune system and immune-mediated diseases

Journal

CLINICAL IMMUNOLOGY
Volume 180, Issue -, Pages 5-10

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2017.03.013

Keywords

E4BP4; Mouse models; Cellular processes; Immune-mediated-diseases

Categories

Funding

  1. National Natural Science Foundation of China [81220108017, 81430074, 81301357, 30972745]
  2. National Institutes of Health [R01 AI090901, AI121196, AI123253]
  3. Research Fund for Postgraduate Innovation Project of Central South University [2015zzts309]

Ask authors/readers for more resources

Basic leucine zipper transcription factor E4BP4 (also known as NFIL3) has been implicated in the molecular and cellular mechanisms of functions and activities in mammals. The interactions between E4BP4 and major regulators of cellular processes have triggered significant interest in the roles of E4BP4 in the pathogenesis of certain chronic diseases. Indeed, novel discoveries have been emerging to illustrate the involvement of E4BP4 in multiple disorders. It is recognized that E4BP4 is extensively involved in some immune-mediated diseases, but the mechanisms of E4BP4 involvement in these complex diseases remain poorly defined. Here we review the regulatory mechanisms of E4BP4 engaging in not only the biological function but also the development of immune-mediated diseases, paving the way for future therapies. (C) 2017 Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available